JMI-105
JMI-105 is a potent PfFP-2 (Plasmodium falciparum falcipain-2 protease) inhibitor. JMI-105 inhibits the growth of CQS (3D7; IC50=8.8 µM) and CQR (RKL-9; IC50=14.3 µM) strains of P. falciparum. JMI-105 significantly decreases parasitemia and prolonged host survival in a murine model with P. berghei ANKA infection. JMI-105 has the potential to be used as an anti-malarial agent[1].
Product Specifications
CAS Number
2227315-30-0
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/jmi-105.html
Solubility
10 mM in DMSO
Smiles
CC(C1=CC=C(C)C(OCC2=CN(C3=CC=C(OC)C=C3)N=N2)=C1)C
Molecular Formula
C20H23N3O2
Molecular Weight
337.42
References & Citations
[1]Uddin A, et al. Identification and structure-activity relationship (SAR) studies of carvacrol derivatives as potential anti-malarial against Plasmodium falciparum falcipain-2 protease. Bioorg Chem. 2020 Oct;103:104142.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Plasmodium
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2066118-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Friend Leukemia Virus Integration 1 (FLI1)
Sign In for Pricing
View Details MBS2066118-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Friend Leukemia Virus Integration 1 (FLI1)
Sign In for Pricing
View Details MBS2066118-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Friend Leukemia Virus Integration 1 (FLI1)
Sign In for Pricing
View Details MBS2066118-04 1 mL
Cy3-Linked Polyclonal Antibody to Friend Leukemia Virus Integration 1 (FLI1)
Sign In for Pricing
View Details MBS2066118-05 5 mL
Cy3-Linked Polyclonal Antibody to Friend Leukemia Virus Integration 1 (FLI1)
Sign In for Pricing
View Details